UKMi Q&A xx - SPS

4.2.3 Therapies targeting NO pathway: phosphodiesterase (PDE) type 5 inhibitors When compared with expression of PDE-5 in other tissues such as the penile corpus cavernosum and the myocardium, the expression and activity of PDE-5 is considerably higher in lung and in pulmonary vascular smooth muscle cells (Corbin, Beasley et al. 2005). ................
................